Immunoprecise Antibodies Ltd
IPA1.779USD
+0.139+8.48%
Horário de mercado （ET）Cotações atrasadas em 15 min
82.11MValor de mercado
PerdaP/L TTM
Mais detalhes de Immunoprecise Antibodies Ltd Empresa
ImmunoPrecise Antibodies Ltd. is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies. It has several subsidiaries in North America and Europe including entities, such as Talem Therapeutics LLC, BioStrand BV, ImmunoPrecise Antibodies (Canada) Ltd. and ImmunoPrecise Antibodies (Europe) B.V. (collectively, the IPA Family). Its Contract Research Organizations (CRO) services include B cell Select; Phage Display; DeepDisplay; Abthena Bispecifics; LucinaTech Humanization; Affinity Maturation; Immunization, hybridoma, sequencing; rPEx protein manufacturing, and Cell line development. The Company utilizes custom antigen modeling, target analysis using Natural Language Processing and the HYFTTM analysis to lay the groundwork for the subsequent experimental phases.
Informações da empresa
Código da empresaIPA
Nome da EmpresaImmunoprecise Antibodies Ltd
Data de listagemJan 30, 1987
CEODr. Jennifer Lynne Bath, Ph.D.
Número de funcionários- -
Tipo de títulosOrdinary Share
Fim do ano fiscalJan 30
EndereçoIndustrious 823 Congress Ave Suite 300
CidadeAUSTIN
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal78701
Telefone16048060626
Sitehttps://www.ipatherapeutics.com/
Código da empresaIPA
Data de listagemJan 30, 1987
CEODr. Jennifer Lynne Bath, Ph.D.
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Jennifer Lynne Bath, Ph.D.
Dr. Jennifer Lynne Bath, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
498.12K
--
Mr. Dirk Witters
Mr. Dirk Witters
Independent Director
Independent Director
1.95K
--
Ms. Kari Graber
Ms. Kari Graber
Vice President - Commercial Services
Vice President - Commercial Services
700.00
--
Mr. Jonathan I. (Jon) Lieber
Mr. Jonathan I. (Jon) Lieber
Director
Director
--
--
Dr. Ilse Roodink, Ph.D.
Dr. Ilse Roodink, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Dr. Kamil Isaev
Dr. Kamil Isaev
Director
Director
--
--
Mr. Barry A. Springer
Mr. Barry A. Springer
Independent Director
Independent Director
--
--
Mr. Joseph Scheffler
Mr. Joseph Scheffler
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Jennifer Lynne Bath, Ph.D.
Dr. Jennifer Lynne Bath, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
498.12K
--
Mr. Dirk Witters
Mr. Dirk Witters
Independent Director
Independent Director
1.95K
--
Ms. Kari Graber
Ms. Kari Graber
Vice President - Commercial Services
Vice President - Commercial Services
700.00
--
Mr. Jonathan I. (Jon) Lieber
Mr. Jonathan I. (Jon) Lieber
Director
Director
--
--
Dr. Ilse Roodink, Ph.D.
Dr. Ilse Roodink, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Dr. Kamil Isaev
Dr. Kamil Isaev
Director
Director
--
--
Detalhamento da receita
Moeda: CADAtualizado em: dom, 6 de jul
Moeda: CADAtualizado em: dom, 6 de jul
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
Por EmpresaCAD
Nome
Receita
Proporção
Project revenue
5.57M
90.59%
Product sales revenue
501.00K
8.15%
Cryo storage revenue
78.00K
1.27%
Por RegiãoCAD
Nome
Receita
Proporção
United States of America
2.88M
46.90%
Europe
2.72M
44.19%
Australia
383.00K
6.23%
Other
112.00K
1.82%
Canada
53.00K
0.86%
Por Empresa
Por Região
Por EmpresaCAD
Nome
Receita
Proporção
Project revenue
5.57M
90.59%
Product sales revenue
501.00K
8.15%
Cryo storage revenue
78.00K
1.27%
Distribuição de ações
Atualizado em: sáb, 12 de jul
Atualizado em: sáb, 12 de jul
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Charmquark TWEE
7.92%
Ingalls & Snyder LLC (Asset Management)
6.02%
Susquehanna International Group, LLP
1.52%
Bath (Jennifer Lynne)
1.08%
Two Sigma Investments, LP
0.20%
Other
83.26%
Investidores
Investidores
Proporção
Charmquark TWEE
7.92%
Ingalls & Snyder LLC (Asset Management)
6.02%
Susquehanna International Group, LLP
1.52%
Bath (Jennifer Lynne)
1.08%
Two Sigma Investments, LP
0.20%
Other
83.26%
Tipos de investidores
Investidores
Proporção
Corporation
7.99%
Investment Advisor/Hedge Fund
6.14%
Investment Advisor
1.82%
Individual Investor
1.34%
Research Firm
0.35%
Hedge Fund
0.26%
Family Office
0.04%
Venture Capital
0.04%
Other
82.02%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
45
8.20M
23.19%
+1.46M
2025Q1
45
6.32M
13.81%
+742.61K
2024Q4
45
4.34M
9.53%
-1.30M
2024Q3
46
5.39M
19.68%
+72.87K
2024Q2
48
5.12M
19.96%
-156.62K
2024Q1
50
5.14M
20.20%
-196.19K
2023Q4
58
5.33M
20.96%
+124.72K
2023Q3
50
4.91M
19.67%
-438.42K
2023Q2
53
5.01M
20.08%
-885.29K
2023Q1
54
5.19M
20.83%
-561.90K
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Charmquark TWEE
1.83M
4%
-1.30M
-41.62%
Dec 31, 2024
Ingalls & Snyder LLC (Asset Management)
2.76M
6.03%
+1.20M
+76.65%
Mar 31, 2025
Susquehanna International Group, LLP
703.00K
1.54%
+703.00K
--
Mar 31, 2025
Bath (Jennifer Lynne)
498.12K
1.09%
+237.30K
+90.98%
Dec 16, 2024
Two Sigma Investments, LP
90.58K
0.2%
+90.58K
--
Mar 31, 2025
Virtu Americas LLC
57.85K
0.13%
+37.09K
+178.66%
Mar 31, 2025
CIBC World Markets Inc.
41.20K
0.09%
--
--
Mar 31, 2025
Thoroughbred Financial Services LLC
40.00K
0.09%
+40.00K
--
Mar 31, 2025
Group One Trading, L.P.
30.06K
0.07%
+30.00K
+49180.33%
Mar 31, 2025
Levine (Mitchell S)
30.00K
0.07%
+10.00K
+50.00%
Aug 01, 2024
Ver Mais
ETFs Relacionados
Nome
Proporção
Sem dados
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
